Document is current
Any future updates will be listed below
-
Authors
Jackson, Sarah E.
Brown, Jamie
Oldham, Melissa
Shahab, Lion
Kock, Loren
-
Funding
Funding for this research was provided by:
Cancer Research UK (PRCRPG-Nov21\100002)
Cancer Research UK (PRCRPG-Nov21\100002)
Cancer Research UK (PRCRPG-Nov21\100002)
Cancer Research UK (PRCRPG-Nov21\100002)
Cancer Research UK (PRCRPG-Nov21\100002)
UK Prevention Research Partnership (MR/ S037519/1)
- License Information
-
More Information
Article History
Received: 3 April 2025
Accepted: 28 April 2026
First Online: 6 May 2026
Declarations
:
: Ethical approval for the STS was granted originally by the UCL Ethics Committee (ID 0498/001). The data are not collected by UCL and are anonymised when received by UCL. The study was conducted in accordance with the Declaration of Helsinki. All participants provided informed verbal consent.
: Not applicable.
: JB has received (most recently in 2018) unrestricted research funding from Pfizer and J&J, who manufacture smoking cessation medications. LS has received honoraria for talks, unrestricted research grants and travel expenses to attend meetings and workshops from manufactures of smoking cessation medications (Pfizer; J&J), and has acted as paid reviewer for grant awarding bodies and as a paid consultant for health care companies. All authors declare no financial links with tobacco companies, e-cigarette manufacturers, or their representatives.
